1. IMPORTANT: In the next few weeks, we will be upgrading the message board software. We expect minimal downtime during the upgrade, and we will attempt to complete this during low-traffic hours. We will post an exact time several days ahead of the switch.

    In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to reminisce or reconnect, as they will remain open for posting. We may also remove some board threads that have been inactive for several years.
    Dismiss Notice

Pain Start Date?

Discussion in 'Vertex' started by anonymous, Jan 10, 2024 at 9:39 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    it will be interesting to see how this plays out, and if the stock gets a big pop upon approval. If it does, probably a good time to go short. I think there are a lot of high expectations built into this drug, and I frankly think it’s going to fall quite a bit short.
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

    I think this a great opportunity with a great company. Leadership is solid, company has cash and assets. Data is single arm vs double arm. Still a lot to be worked out but Suz will eventually take over opioid space due to efforts of this launch team.
     
  4. anonymous

    anonymous Guest

    Double arm? That’s some serious kink!
     
  5. anonymous

    anonymous Guest

    Bawahahaha, you’re so gullible!!!!
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    ummmm what? Double arm? Were you hired? That explains A LOT!
     
  8. anonymous

    anonymous Guest

    These last few posts make as much sense as the management decisions here.
    Time to move on from these posts. It’s a shame but without new material
    no reason to post.
     
  9. anonymous

    anonymous Guest

    Whatever you are on... I need some... This drug launch is not going to be easy.. Data was not impressive..
     
  10. anonymous

    anonymous Guest

     
  11. anonymous

    anonymous Guest

    total value based shares of 45k each year, with proportional graded vesting for each share set over 3 years
     
  12. anonymous

    anonymous Guest

    same
     
  13. anonymous

    anonymous Guest

    for me it was the annual RSU each year that sold me, way to invest in your people! the novel selective non-opioid moa will have challengers but selling transformation isn't always for the local pharma rep with a catering app
     
  14. anonymous

    anonymous Guest

    yes easy was what i was expecting for a total comp of 270k
     
  15. anonymous

    anonymous Guest

    wring again. Read the information. This is the issue people on the street think they are smarter than the science. It is another option for the people suffering in pain. It is likely non addictive. It is an alternative to the limited offerings on the market.

    enough of the predictions get out there and sell.
     
  16. anonymous

    anonymous Guest

    Stop thinking and sell. Do you have a MBA in sales? Do you have a market access analysis? What about eveine who is at risk for addiction. I’ll take it tomorrow stop by. And pick me up a sandwich

    sell it before the competition arrives. Fools.
     
  17. anonymous

    anonymous Guest


    Learn to spell and compose a sentence before you call someone else a fool.
     
  18. anonymous

    anonymous Guest

    I guess you’re the type that needs things easy to be successful. If that’s the case then be glad you didn’t get the offer. Enjoy your current job, survive the next round of layoffs and you’ll be fine. I’ll be enjoying myself here as well.
     
  19. anonymous

    anonymous Guest

    I’ll say it again. Fool. And I’ll work on spelling better. Cut the chatter and read the data. This won’t be a dog unless you make it one. Failed launches do happen and if not vertex the next pharma in line will do it. Plenty of players in the rear view.

    Cutting yourself short. Fools.
     
  20. anonymous

    anonymous Guest

    Relax. Collect your check. Begin to vest yesr after yesr in the rsu. The drug has a good likelihood to be delayed. Enjoy more prep time and collect the check.
    No matter what do not challenge the strategy. The biggest mistake u can make is to question anything they tell you.
    The hospital sales will be near the zero range after first year. Script sales will be slow first year but you have potential.
    It will not be huge but you just need to collect the check, not question, enjoy the generous vacation time and pray your manager is not a dick or too micro.
    If you don’t know her you will soon see the regional Dir for the Northeast is very stupid. Her greatest achievement is telling you how many jobs she has had. She was Dei before there was dei.